Gyan Kapur is a venture capital investor at Surface Ventures and Bayes Ventures who personally built a real-time analytics stack in two days to track portfolio risk, reflecting his unusually hands-on technical approach to venture decision-making. He combines deep healthcare experience from Gather Health with complex financial products background from Citigroup's foreign-exchange derivatives business, focusing on B2B investments across health IT and enterprise SaaS with $250K-$4M checks.

• Deep interest in healthcare innovation and life sciences, ranging from digital health to complex biotech research. Tweets frequently track developments in senescent cells, potential precursors for Alzheimer's drugs, and the operational challenges of recruiting patients for precision oncology clinical trials.
• Specific investment thesis regarding B2B SaaS and customer success tools. Explicitly called for founders building a bottom-up alternative to Gainsight that focuses on measuring ROI and offers quick setup, noting that price increases by private equity-backed incumbents create real market openings.
• Attention to technical milestones in artificial intelligence and developer infrastructure. Highlighted state of the art results for Poetiq regarding tool calling benchmarks and shared content about cloud-native software development tools for Kubernetes.
• Engagement with the financial technology sector. Promoted the new class of fintech disruptors at the Barclays accelerator powered by Techstars and has shared interest in consumer savings and investment platforms like Yotta and Public.
• Consistent pattern of celebrating portfolio progress and founder milestones to amplify their reach. Regularly posts congratulations for seed funding rounds or impressive early-stage results, such as the work done by the PerformicaHR team or efforts to protect the US from future pandemics.